Chimeron Bio

Chimeron Bio Corporation is a Philadelphia-based company established in 2015 that specializes in the discovery and development of personalized immunotherapeutics for cancer treatment. The company focuses on creating self-amplifying therapeutics and vaccines, utilizing a unique platform that employs chimera-encased self-amplifying RNA. This innovative approach allows for superior expression levels and a wider dynamic range compared to traditional messenger RNA technologies. Chimeron Bio aims to provide effective gene therapies and personalized medicine solutions for patients suffering from serious diseases, including cancer, infectious diseases, and genetic disorders.